Implantable Defibrillators Market byType (Single Chambered, Double Chambered, Biventricular Chambered), Procedure Type (Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Cardiac Resynchronization Therapy Defibrillator (CRT-D)), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Implantable Defibrillators Market

Industry:  Life Sciences & Healthcare | Publish Date: Oct 2020 | No of Pages:  320 | No. Tables:  162 | No. Figures:  102

Market Definition:

The Global Implantable Defibrillators Market was valued at USD 7.35 billion in 2019 and is expected to garner USD 11.44 billion by 2030, registering a CAGR of 4.1% during the forecast period 2020 - 2030.

Implantable defibrillator is a device powered by a tiny battery that is placed in the chest of a patient in order to monitor the heartbeat and prevent sudden cardiac arrest by delivering shocks at times of abnormal heart beat. The electric shocks delivered by implantable defibrillators depolarizes heart muscles and restores the normal heart rhythm. This device is recommended to people, who have survived one or more cardiac arrest and with persisting problem of irregular heartbeats even after proper medications.

Market Dynamics and Trends:

Globally, it has been observed that the maximum causes of deaths are caused due to heart diseases. The rapid increase in the geriatric population and upraised risk of cardio vascular diseases are the key drivers of implantable defibrillator market growth. Moreover, the exposure of new technology and increase in adoption of implantable defibrillators will lead to spontaneous growth of the defibrillator market.

On the contrary, the risk factors like infection in the implanted area, sudden damage to the veins where ICD leads are placed, bleeding around the heart are some factors that hinders the growth of implantable defibrillator market. However, the increasing population along with the rising mortality due to cardiac arrests and other heart disease will provide ample opportunities for the implantable heart defibrillator market players to grow and flourish globally.

 

Market Segmentations and Scope of the Study:

The implantable defibrillators market is segmented on the basis of product type and geography. On the basis of product type, market is divided into transvenous implantable cardioverter-defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillators (S-ICDS), and cardiac resynchronization therapy defibrillator (CRT-D). Geographically, the market is spread across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and rest of the world (RoW).

 

Geographical Analysis:

North America dominates the Implantable Defibrillators market as a result of better and advanced medical facilities as well as healthcare centres, compared to other regions. Also, the rising mortality rate due to heart diseases in this region is another underlying factor contributing to the adoption of implantable defibrillators. 

The Asia Pacific region is predicted to show consistent growth in terms of market share within the forecast period as the manufacturers of this region are focusing on introducing advanced but cost-effective defibrillator devices to meet the needs of the dense and rapid growing population of this region. Moreover, the unhealthy life style of the people in this region like lack of exercise, consumption of excess oil and spices with food, cigarette smoking and absence of balanced diet leading to increase in cholesterol levels, resulting in cardiovascular diseases will provide ample opportunities for the implantable defibrillators market to grow in the coming years.

 

Competitive Landscape:

The key players operating in the global implantable defibrillators market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.

KEY BENEFITS:

  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

  • Comprehensive analysis of factors that drive and restrict the implantable defibrillators market growth is provided in the report.

  • This report provides an extensive analysis of the current & emerging market trends and dynamics in the global implantable defibrillators market.

  • Region- and country-wise market conditions are analysed in the report.

KEY MARKET SEGMENTS:

By Type

  • Single Chamber

  • Double Chambered

  • Biventricular Chambered

By Procedure Type

  • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

  • Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)

  • Cardiac Resynchronization Therapy Defibrillator (CRT-D)

By End User

  • Hospitals

  • Speciality Clinics

  • Ambulatory Surgical Centers

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • Australia

    • India

    • Rest of Asia-Pacific

  • RoW

    • Brazil

    • Argentina

    • Egypt

    • Israel

    • South Africa

    • Rest of RoW

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2019–2030

Base Year Considered

2020

Forecast Period

2020–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Product Type (Subcutaneous Implantable Cardioverter Defibrillators, Transvenous Implantable Cardioverter-Defibrillator, Cardiac Resynchronization Therapy Defibrillator)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Rest of the World (Brazil, Argentina, Egypt, Israel, South Africa, Remaining Countries)

Companies Profiled

Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.
column chart pie chart

1.     INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Research Methodology

1.2.1             Secondary Research

1.2.2             Data Analysis Framework

1.2.3             Market size estimation

1.2.4             Forecasting

1.2.5             Primary Research and Data Validation

2.      MARKET SNAPSHOT, 2019-2030 MILLION USD/VOLUME

2.1.           MARKET SNAPSHOT

3.      PORTER’S FIVE FORCE MODEL ANALYSIS

4.      MARKET DYNAMICS

4.1.           GROWTH DRIVERS

4.1.1             DRIVER 1

4.1.2             DRIVER 2

4.1.3             DRIVER 3

4.1.4             DRIVER 4

4.2.           CHALLENGES

4.2.1             CHALLENGE 1

4.2.2             CHALLENGE 2

4.3.           OPPORTUNITIES

4.3.1             OPPORTUNITY 1

4.3.2             OPPORTUNITY 2

5.      Global  Implantable Defibrillators Market, By Product Type

5.1.           Overview

5.2.          Subcutaneous Implantable Cardioverter Defibrillators

5.2.1             Subcutaneous Implantable Cardioverter Defibrillators Market, By Region

5.2.1.1        North America Subcutaneous Implantable Cardioverter Defibrillators Market, By Country

5.2.1.2        Europe Subcutaneous Implantable Cardioverter Defibrillators Market, By Country

5.2.1.3        Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillators Market, By Country

5.2.1.4        Rest of World Subcutaneous Implantable Cardioverter Defibrillators Market, By Country

5.3.          Transvenous Implantable Cardioverter-Defibrillator

5.3.1             Transvenous Implantable Cardioverter-Defibrillator Market, By Region

5.3.1.1        North America Transvenous Implantable Cardioverter-Defibrillator Market, By Country

5.3.1.2        Europe Transvenous Implantable Cardioverter-Defibrillator Market, By Country

5.3.1.3        Asia-Pacific Transvenous Implantable Cardioverter-Defibrillator Market, By Country

5.3.1.4        Rest of World Transvenous Implantable Cardioverter-Defibrillator Market, By Country

5.4.           Cardiac Resynchronization Therapy Defibrillator

5.4.1             Cardiac Resynchronization Therapy Defibrillator Market, By Region

5.4.1.1        North America Cardiac Resynchronization Therapy Defibrillator Market, By Country

5.4.1.2        Europe Cardiac Resynchronization Therapy Defibrillator Market, By Country

5.4.1.3        Asia-Pacific Cardiac Resynchronization Therapy Defibrillator Market, By Country

5.4.1.4        Rest of World Cardiac Resynchronization Therapy Defibrillator Market, By Country

6.      Global  Implantable Defibrillators Market, By Region

6.1.           Overview

6.2.           North America

6.2.1             North America Implantable Defibrillators Market, By Product Type

6.2.2             North America Implantable Defibrillators, Market By Country

6.2.2.1        U.S.

6.2.2.1.1        U.S. Implantable Defibrillators Market, By Product Type

6.2.2.2        Canada

6.2.2.2.1        Canada Implantable Defibrillators Market, By Product Type

6.2.2.3        Mexico

6.2.2.3.1        Mexico Implantable Defibrillators Market, By Product Type

6.3.           Europe

6.3.1             Europe Implantable Defibrillators Market, By Product Type

6.3.2             Europe Implantable Defibrillators, Market By Country

6.3.2.1        Germany

6.3.2.1.1        Germany Implantable Defibrillators Market, By Product Type

6.3.2.2        UK

6.3.2.2.1        UK Implantable Defibrillators Market, By Product Type

6.3.2.3        France

6.3.2.3.1        France Implantable Defibrillators Market, By Product Type

6.3.2.4        Italy

6.3.2.4.1        Italy Implantable Defibrillators Market, By Product Type

6.3.2.5        Spain

6.3.2.5.1        Spain Implantable Defibrillators Market, By Product Type

6.3.2.6        Rest of Europe

6.3.2.6.1        Rest of Europe Implantable Defibrillators Market, By Product Type

6.4.           Asia-Pacific

6.4.1             Asia-Pacific Implantable Defibrillators Market, By Product Type

6.4.2             Asia-Pacific Implantable Defibrillators, Market By Country

6.4.2.1        China

6.4.2.1.1        China Implantable Defibrillators Market, By Product Type

6.4.2.2        India

6.4.2.2.1        India Implantable Defibrillators Market, By Product Type

6.4.2.3        Japan

6.4.2.3.1        Japan Implantable Defibrillators Market, By Product Type

6.4.2.4        Australia

6.4.2.4.1        Australia Implantable Defibrillators Market, By Product Type

6.4.2.5        Rest of Asia-Pacific

6.4.2.5.1        Rest of Asia-Pacific Implantable Defibrillators Market, By Product Type

6.5.           Rest of World

6.5.1             Rest of World Implantable Defibrillators Market, By Product Type

6.5.2             Rest of World Implantable Defibrillators, Market By Country

6.5.2.1        Brazil

6.5.2.1.1        Brazil Implantable Defibrillators Market, By Product Type

6.5.2.2        South Africa

6.5.2.2.1        South Africa Implantable Defibrillators Market, By Product Type

6.5.2.3        Argentina

6.5.2.3.1        Argentina Implantable Defibrillators Market, By Product Type

6.5.2.4        Egypt

6.5.2.4.1        Egypt Implantable Defibrillators Market, By Product Type

6.5.2.5        Israel

6.5.2.5.1        Israel Implantable Defibrillators Market, By Product Type

6.5.2.6        Remaining Countries

6.5.2.6.1        Remaining Countries Implantable Defibrillators Market, By Product Type

7.      COMPANY PROFILES

7.1.           BOSTON SCIENTIFIC CORPORATION

7.1.1             COMPANY OVERVIEW

7.1.2             COMPANY SNAPSHOT

7.1.3             OPERATING BUSINESS SEGMENTS

7.1.4             PRODUCT PORTFOLIO

7.1.5             BUSINESS PERFORMANCE

7.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.2.           LIVANOVA PLC COMPANY

7.2.1             COMPANY OVERVIEW

7.2.2             COMPANY SNAPSHOT

7.2.3             OPERATING BUSINESS SEGMENTS

7.2.4             PRODUCT PORTFOLIO

7.2.5             BUSINESS PERFORMANCE

7.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.3.           IMRICOR MEDICAL SYSTEMS

7.3.1             COMPANY OVERVIEW

7.3.2             COMPANY SNAPSHOT

7.3.3             OPERATING BUSINESS SEGMENTS

7.3.4             PRODUCT PORTFOLIO

7.3.5             BUSINESS PERFORMANCE

7.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.4.           MICROPORT SCIENTIFIC CORPORATION

7.4.1             COMPANY OVERVIEW

7.4.2             COMPANY SNAPSHOT

7.4.3             OPERATING BUSINESS SEGMENTS

7.4.4             PRODUCT PORTFOLIO

7.4.5             BUSINESS PERFORMANCE

7.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.5.           MAYO CLINIC US

7.5.1             COMPANY OVERVIEW

7.5.2             COMPANY SNAPSHOT

7.5.3             OPERATING BUSINESS SEGMENTS

7.5.4             PRODUCT PORTFOLIO

7.5.5             BUSINESS PERFORMANCE

7.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.6.           MEDTRONIC PLC

7.6.1             COMPANY OVERVIEW

7.6.2             COMPANY SNAPSHOT

7.6.3             OPERATING BUSINESS SEGMENTS

7.6.4             PRODUCT PORTFOLIO

7.6.5             BUSINESS PERFORMANCE

7.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.7.           MRI INTERVENTIONS, INC.

7.7.1             COMPANY OVERVIEW

7.7.2             COMPANY SNAPSHOT

7.7.3             OPERATING BUSINESS SEGMENTS

7.7.4             PRODUCT PORTFOLIO

7.7.5             BUSINESS PERFORMANCE

7.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.8.           ST. JUDE MEDICAL, INC.

7.8.1             COMPANY OVERVIEW

7.8.2             COMPANY SNAPSHOT

7.8.3             OPERATING BUSINESS SEGMENTS

7.8.4             PRODUCT PORTFOLIO

7.8.5             BUSINESS PERFORMANCE

7.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.9.           BIOTRONIK SE & CO.KG

7.9.1             COMPANY OVERVIEW

7.9.2             COMPANY SNAPSHOT

7.9.3             OPERATING BUSINESS SEGMENTS

7.9.4             PRODUCT PORTFOLIO

7.9.5             BUSINESS PERFORMANCE

7.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

7.10.         SORIN GROUP

7.10.1           COMPANY OVERVIEW

7.10.2           COMPANY SNAPSHOT

7.10.3           OPERATING BUSINESS SEGMENTS

7.10.4           PRODUCT PORTFOLIO

7.10.5           BUSINESS PERFORMANCE

7.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1.         Global  Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 2.         Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 3.         North America Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 4.         Europe Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 5.         Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 6.         Rest of World Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 7.         Transvenous Implantable Cardioverter-Defibrillator Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 8.         North America Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 9.         Europe Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 10.       Asia-Pacific Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 11.       Rest of World Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 12.       Cardiac Resynchronization Therapy Defibrillator Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 13.       North America Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 14.       Europe Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 15.       Asia-Pacific Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 16.       Rest of World Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

TABLE 17.       Global  Implantable Defibrillators Market Value, By Region, 2019-2030, MILLION USD/VOLUME

TABLE 18.       North America Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 19.       U.S. Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 20.       Canada Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 21.       Mexico Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 22.       Europe Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 23.       Germany Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 24.       UK Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 25.       France Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 26.       Italy Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 27.       Spain Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 28.       Rest of Europe Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 29.       Asia-Pacific Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 30.       China Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 31.       India Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 32.       Japan Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 33.       Australia Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 34.       Rest of Asia-Pacific Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 35.       Rest of World Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 36.       Brazil Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 37.       South Africa Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 38.       Argentina Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 39.       Egypt Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 40.       Israel Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 41.       Remaining Countries Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

TABLE 42.       BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 43.       BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 44.       BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 45.       BOSTON SCIENTIFIC CORPORATION: KEY STRATERGY

TABLE 46.       LIVANOVA PLC COMPANY: COMPANY SNAPSHOT

TABLE 47.       LIVANOVA PLC COMPANY: OPERATING SEGMENTS

TABLE 48.       LIVANOVA PLC COMPANY: PRODUCT PORTFOLIO

TABLE 49.       LIVANOVA PLC COMPANY: KEY STRATERGY

TABLE 50.       IMRICOR MEDICAL SYSTEMS: COMPANY SNAPSHOT

TABLE 51.       IMRICOR MEDICAL SYSTEMS: OPERATING SEGMENTS

TABLE 52.       IMRICOR MEDICAL SYSTEMS: PRODUCT PORTFOLIO

TABLE 53.       IMRICOR MEDICAL SYSTEMS: KEY STRATERGY

TABLE 54.       MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 55.       MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 56.       MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 57.       MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGY

TABLE 58.       MAYO CLINIC US: COMPANY SNAPSHOT

TABLE 59.       MAYO CLINIC US: OPERATING SEGMENTS

TABLE 60.       MAYO CLINIC US: PRODUCT PORTFOLIO

TABLE 61.       MAYO CLINIC US: KEY STRATERGY

TABLE 62.       MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 63.       MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 64.       MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 65.       MEDTRONIC PLC: KEY STRATERGY

TABLE 66.       MRI INTERVENTIONS, INC.: COMPANY SNAPSHOT

TABLE 67.       MRI INTERVENTIONS, INC.: OPERATING SEGMENTS

TABLE 68.       MRI INTERVENTIONS, INC.: PRODUCT PORTFOLIO

TABLE 69.       MRI INTERVENTIONS, INC.: KEY STRATERGY

TABLE 70.       ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 71.       ST. JUDE MEDICAL, INC.: OPERATING SEGMENTS

TABLE 72.       ST. JUDE MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 73.       ST. JUDE MEDICAL, INC.: KEY STRATERGY

TABLE 74.       BIOTRONIK SE & CO.KG: COMPANY SNAPSHOT

TABLE 75.       BIOTRONIK SE & CO.KG: OPERATING SEGMENTS

TABLE 76.       BIOTRONIK SE & CO.KG: PRODUCT PORTFOLIO

TABLE 77.       BIOTRONIK SE & CO.KG: KEY STRATERGY

TABLE 78.       SORIN GROUP: COMPANY SNAPSHOT

TABLE 79.       SORIN GROUP: OPERATING SEGMENTS

TABLE 80.       SORIN GROUP: PRODUCT PORTFOLIO

TABLE 81.       SORIN GROUP: KEY STRATERGY

 

 

LIST OF FIGURES

FIGURE 1.       Global  Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 2.       Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 3.       North America Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 4.       Europe Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 5.       Asia-Pacific Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 6.       Rest of World Subcutaneous Implantable Cardioverter Defibrillators Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 7.       Transvenous Implantable Cardioverter-Defibrillator Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 8.       North America Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 9.       Europe Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 10.     Asia-Pacific Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 11.     Rest of World Transvenous Implantable Cardioverter-Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 12.     Cardiac Resynchronization Therapy Defibrillator Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 13.     North America Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 14.     Europe Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 15.     Asia-Pacific Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 16.     Rest of World Cardiac Resynchronization Therapy Defibrillator Market Value, By Country, 2019-2030, MILLION USD/VOLUME

FIGURE 17.     Global  Implantable Defibrillators Market Value, By Region, 2019-2030, MILLION USD/VOLUME

FIGURE 18.     North America Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 19.     U.S. Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 20.     Canada Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 21.     Mexico Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 22.     Europe Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 23.     Germany Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 24.     UK Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 25.     France Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 26.     Italy Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 27.     Spain Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 28.     Rest of Europe Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 29.     Asia-Pacific Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 30.     China Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 31.     India Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 32.     Japan Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 33.     Australia Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 34.     Rest of Asia-Pacific Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 35.     Rest of World Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 36.     Brazil Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 37.     South Africa Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 38.     Argentina Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 39.     Egypt Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 40.     Israel Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 41.     Remaining Countries Implantable Defibrillators Market Value, By Product Type, 2019-2030, MILLION USD/VOLUME

FIGURE 42.     BOSTON SCIENTIFIC CORPORATION: NET SALES,2017-2019

FIGURE 43.     LIVANOVA PLC COMPANY: NET SALES,2017-2019

FIGURE 44.     IMRICOR MEDICAL SYSTEMS: NET SALES,2017-2019

FIGURE 45.     MICROPORT SCIENTIFIC CORPORATION: NET SALES,2017-2019

FIGURE 46.     MAYO CLINIC US: NET SALES,2017-2019

FIGURE 47.     MEDTRONIC PLC: NET SALES,2017-2019

FIGURE 48.     MRI INTERVENTIONS, INC.: NET SALES,2017-2019

FIGURE 49.     ST. JUDE MEDICAL, INC.: NET SALES,2017-2019

FIGURE 50.     BIOTRONIK SE & CO.KG: NET SALES,2017-2019

FIGURE 51.     SORIN GROUP: NET SALES,2017-2019

KEY PLAYERS:

  • Boston Scientific Corporation
  • LivaNova PLC Company
  • Imricor Medical Systems
  • MicroPort Scientific Corporation
  • Mayo Clinic US
  • Medtronic plc
  • MRI Interventions Inc.
  • St. Jude Medical Inc.
  • Biotronik Se & Co.KG
  • Sorin Group

Frequently Asked Questions
What will be the worth of global Implantable Defibrillators Market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Implantable Defibrillators Market business is expected to hit at $11.44 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Implantable Defibrillators Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Implantable Defibrillators Industry?

Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG

What are the market segmentations and scope of the study?

The global Implantable Defibrillators Market share analysis is based on product type and geography.

How big is the Implantable Defibrillators Market?

Currently (in 2019), the market value stands at USD 7.35 billion and it is anticipated to reach USD 11.44 billion by 2030.